BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Dexamethasone (Dextenza) readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of Dexamethasone (Dextenza)\, from ClinicalT
 rials.gov estimates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT06235567-11043@assetmemo.bio
DTSTAMP:20261121T005650Z
DTSTART;VALUE=DATE:20261231
DTEND;VALUE=DATE:20270101
SUMMARY:Dexamethasone (Dextenza): Phase 1/2 readout est. (NCT06235567)
DESCRIPTION:Dexamethasone (Dextenza)\, phase 1/2.\nStudy: Dextenza Versus T
 opical Steroid Eye Drops for Postoperative Management Following Corneal Cr
 osslinking\nEstimated primary completion: December 2026. This is a Clinica
 lTrials.gov estimate\, not a confirmed readout date\, and it can move.\nDr
 ug page: https://assetmemo.bio/drug/dexamethasone-dextenza#upcoming-events
 \nRegistry record: https://clinicaltrials.gov/study/NCT06235567
URL:https://assetmemo.bio/drug/dexamethasone-dextenza#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT04371445-11043@assetmemo.bio
DTSTAMP:20261121T005650Z
DTSTART;VALUE=DATE:20271201
DTEND;VALUE=DATE:20271202
SUMMARY:Dexamethasone (Dextenza): Phase 4 readout est. (NCT04371445)
DESCRIPTION:Dexamethasone (Dextenza)\, phase 4.\nStudy: Dextenza in the Pos
 t-op Management of Vitreoretinal Surgeries\nEstimated primary completion: 
 1 December 2027. This is a ClinicalTrials.gov estimate\, not a confirmed r
 eadout date\, and it can move.\nDrug page: https://assetmemo.bio/drug/dexa
 methasone-dextenza#upcoming-events\nRegistry record: https://clinicaltrial
 s.gov/study/NCT04371445
URL:https://assetmemo.bio/drug/dexamethasone-dextenza#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
